Evidence map›Paper›PMID 19435904›Full record

ArticleCancer research2009

Complex oncogenic translocations with gene amplification are initiated by specific DNA breaks in lymphocytes.

Sarah M Wright, Yong H Woo, Travis L Alley, Bobbi-Jo Shirley, Ellen C Akeson, Kathy J Snow, Sarah A Maas, Rachel L Elwell, Oded Foreman, Kevin D Mills

Open access · bronzeAbstract read
In one paragraph

Article in Cancer research, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Sarah M WrightJoslin Diabetes Center, Boston, MA 02115, USA. Sarah.Wright@joslin.harvard.edu
Yong H Woo
Travis L Alley
Bobbi-Jo Shirley
Ellen C Akeson
Kathy J Snow
Sarah A Maas
Rachel L Elwell
Oded Foreman
Kevin D Mills
Jackson Laboratory · USJoslin Diabetes Center · USMount Desert Island Biological Laboratory · US

Funding

WNT SIGNALING IN PREIMPLANTATION EMBRYOP20RR018789 · NCRR · MAINE MEDICAL CENTER · PI WANG, ZACK Z. · 2003 to 2011
$18.9M
REPRODUCTIVE BIOLOGYT32HD007065 · NICHD · JACKSON LABORATORY · PI BRAUN, ROBERT E · 1985 to 2020
$2.6M
Molecular Mechanisms of LymphomagenesisR01CA115665 · NCI · JACKSON LABORATORY · PI MILLS, KEVIN D · 2006 to 2009
$1.2M
NCI NIH HHS 5 R01 CA115665-03NCI NIH HHS R01 CA115665NCRR NIH HHS 2 P20 RR018789-06NCRR NIH HHS P20 RR018789NICHD NIH HHS T32 HD007065
6 · The paper itself

Abstract

Chromosomal instability is a hallmark of many tumor types. Complex chromosomal rearrangements with associated gene amplification, known as complicons, characterize many hematologic and solid cancers. Whereas chromosomal aberrations, including complicons, are useful diagnostic and prognostic cancer markers, their molecular origins are not known. Although accumulating evidence has implicated DNA double-strand break repair in suppression of oncogenic genome instability, the genomic elements required for chromosome rearrangements, especially complex lesions, have not been elucidated. Using a mouse model of B-lineage lymphoma, characterized by complicon formation involving the immunoglobulin heavy chain (Igh) locus and the c-myc oncogene, we have now investigated the requirement for specific genomic segments as donors for complex rearrangements. We now show that specific DNA double-strand breaks, occurring within a narrow segment of Igh, are necessary to initiate complicon formation. By contrast, neither specific DNA breaks nor the powerful intronic enhancer Emu are required for complicon-independent oncogenesis. This study is the first to delineate mechanisms of complex versus simple instability and the first to identify specific chromosomal elements required for complex chromosomal aberrations. These findings will illuminate genomic cancer susceptibility and risk factors.

Indexed as

Chromosome AberrationsDNA DamageDNA RepairGene AmplificationGene RearrangementGenes, mycTranslocation, GeneticAnimalsDisease Models, AnimalGenetic Predisposition to DiseaseImmunoglobulin Heavy ChainsImmunoglobulin Joining RegionLymphocytesLymphoma, B-CellMiceRisk FactorsImmunoglobulin Heavy ChainsImmunoglobulin Joining Region

Identifiers

PMID19435904
PMCPMC2724672
OpenAlexW2119007787

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.